SURI vs. IBRN

Last updated Jun 24, 2026

SURI (Simplify Propel Opportunities ETF) and IBRN (iShares Neuroscience and Healthcare ETF) are both Health & Biotech Equities funds. SURI is actively managed, while IBRN is passively managed. Over the past 3 years, SURI returned 6.84%/yr vs 14.72%/yr for IBRN. A 0.63 correlation means they provide meaningful diversification when combined. SURI charges 2.51%/yr vs 0.47%/yr for IBRN.

Performance

SURI vs. IBRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Simplify Propel Opportunities ETF (SURI) and iShares Neuroscience and Healthcare ETF (IBRN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SURI achieves a 8.27% return, which is significantly lower than IBRN's 14.14% return.

SURI

• 1D: 1.33%
• 1M: -2.24%
• YTD: 8.27%
• 6M: 9.05%
• 1Y: 27.88%
• 3Y*: 6.84%
• 5Y*: —
• 10Y*: —

IBRN

• 1D: 0.60%
• 1M: 6.49%
• YTD: 14.14%
• 6M: 14.25%
• 1Y: 71.08%
• 3Y*: 14.72%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SURI vs. IBRN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
SURI Simplify Propel Opportunities ETF	8.27%	28.32%	-13.34%	-2.87%
IBRN iShares Neuroscience and Healthcare ETF	14.14%	28.49%	-2.78%	-1.61%

Correlation

The correlation between SURI and IBRN is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.54
Correlation (3Y) Calculated over the trailing 3-year period	0.62
Correlation (All Time) Calculated using the full available price history since Feb 8, 2023	0.63

The correlation between SURI and IBRN has been stable across timeframes, ranging from 0.54 to 0.63 - a consistent structural relationship.

SURI vs. IBRN - Sectors Allocation Comparison

Sectors	SURI	IBRN
Healthcare	56.5%	100.0%
Energy	43.5%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

SURI vs. IBRN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURI

SURI Risk / Return Rank: 40
SURI Sharpe Ratio Rank: 37
SURI Sortino Ratio Rank: 37
SURI Omega Ratio Rank: 34
SURI Calmar Ratio Rank: 52
SURI Martin Ratio Rank: 41

IBRN

IBRN Risk / Return Rank: 89
IBRN Sharpe Ratio Rank: 90
IBRN Sortino Ratio Rank: 88
IBRN Omega Ratio Rank: 80
IBRN Calmar Ratio Rank: 96
IBRN Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SURI vs. IBRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Simplify Propel Opportunities ETF (SURI) and iShares Neuroscience and Healthcare ETF (IBRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SURI	IBRN	Difference
Sharpe ratio: Return per unit of total volatility	1.25	2.80	-1.56
Sortino ratio: Return per unit of downside risk	1.80	3.71	-1.91
Omega ratio: Gain probability vs. loss probability	1.22	1.43	-0.22
Calmar ratio: Return relative to maximum drawdown	2.38	8.12	-5.74
Martin ratio: Return relative to average drawdown	6.30	22.92	-16.62

SURI vs. IBRN - Sharpe Ratio Comparison

The current SURI Sharpe Ratio is 1.25, which is lower than the IBRN Sharpe Ratio of 2.80. The chart below compares the historical Sharpe Ratios of SURI and IBRN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SURI vs. IBRN - Drawdown Comparison

The maximum SURI drawdown since its inception was -47.76%, which is greater than IBRN's maximum drawdown of -35.38%. Use the drawdown chart below to compare losses from any high point for SURI and IBRN.

Drawdown Indicators

	SURI	IBRN	Difference
Max Drawdown Largest peak-to-trough decline	-47.76%	-35.38%	-12.38%
Max Drawdown (1Y) Largest decline over 1 year	-11.78%	-8.80%	-2.98%
Max Drawdown (3Y) Largest decline over 3 years	-47.76%	-35.38%	-12.38%
Current Drawdown Current decline from peak	-15.77%	0.00%	-15.77%
Average Drawdown Average peak-to-trough decline	-17.33%	-9.75%	-7.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.44%	3.11%	+1.33%

Volatility

SURI vs. IBRN - Volatility Comparison

The current volatility for Simplify Propel Opportunities ETF (SURI) is 5.90%, while iShares Neuroscience and Healthcare ETF (IBRN) has a volatility of 8.17%. This indicates that SURI experiences smaller price fluctuations and is considered to be less risky than IBRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SURI	IBRN	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.90%	8.17%	-2.27%
Volatility (6M) Calculated over the trailing 6-month period	14.21%	19.20%	-4.99%
Volatility (1Y) Calculated over the trailing 1-year period	22.48%	25.50%	-3.02%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.16%	25.36%	+2.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.16%	25.36%	+2.80%

SURI vs. IBRN - Expense Ratio Comparison

SURI has a 2.51% expense ratio, which is higher than IBRN's 0.47% expense ratio.

Dividends

SURI vs. IBRN - Dividend Comparison

SURI's dividend yield for the trailing twelve months is around 15.72%, more than IBRN's 0.87% yield.

Position	TTM	2025	2024	2023
IBRN iShares Neuroscience and Healthcare ETF	0.87%	0.99%	0.40%	0.06%
SURI Simplify Propel Opportunities ETF	15.72%	16.31%	21.41%	14.71%

Frequently Asked Questions

Can I hold both SURI and IBRN in my portfolio?

SURI and IBRN have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SURI or IBRN?

IBRN has higher volatility (8.17%) compared to SURI (5.90%). In terms of maximum drawdown, SURI dropped -47.76% vs IBRN's -35.38%.

Which ETF is better, SURI or IBRN?

On 3-year performance, IBRN leads with 14.72% vs 6.84% for SURI. On fees, IBRN is cheaper at 0.47% per year. On volatility, SURI has been the lower-risk option at 5.90%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, SURI or IBRN?

Over the 3-year period, IBRN has performed better with a 14.72% return vs 6.84%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, SURI or IBRN?

IBRN is cheaper with a 0.47% expense ratio, compared with 2.51% for SURI.

Which ETF pays a higher dividend yield, SURI or IBRN?

SURI has the higher dividend yield at 15.72%, compared with 0.87% for IBRN.

What is the main difference between SURI and IBRN?

They also come from different issuers: Simplify and iShares. Their fees differ too: 2.51% for SURI and 0.47% for IBRN.

Which has better risk-adjusted returns?

IBRN currently has the higher Sharpe Ratio (2.80 vs 1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.